We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Myelin-Producing Cells Restore Nerve Function in Mice

By Biotechdaily staff writers
Posted on 21 Jan 2004
By introducing myelin-producing cells in widespread areas of the brain in mice, scientists have been able to restore proper nerve function in nearly the entire brain more efficiently than was previously possible, offering the possibility of treatment for demyelinating diseases. More...
The findings were reported in the January 2004 issue of Nature Medicine.

Myelin is a fatty substance that covers nearly all the nerve cells in the body and helps signals in the nervous system go from one point to another. When myelin breaks down, electrical signals degrade. This can result in a number of disorders as well as such diseases as Canavan disease in children and multiple sclerosis (MS). Currently, demyelinating diseases are permanent, with no available therapy.

The investigators remyelinated the mice by injecting highly purified human progenitor cells, which ultimately evolved into the cells that make myelin, called oligodendrocytes. They studied 44 mice born without any myelin wrapped around their brain cells. Within 24 hours, they injected the mice and found that the cells quickly migrated throughout the brain, developing into oligodendrocytes and producing myelin. The team found that adult human cells were much more adept at settling into the brain, becoming oligodendrocytes and producing myelin, than fetal cells.

"The results are much better than we expected,” said team leader Steven Goldman, M.D., Ph.D., professor of neurology at the University of Rochester Medical Center (NY, USA; www.rochester.edu). "The percentage of cells in this experiment that began producing myelin is extraordinary, probably thousands of times as many as in previous experiments.”




Related Links:
University of Rochester

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Rapid Sepsis Test
SeptiCyte RAPID
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.